NKGNW logo

NKGen Biotech Warrants (NKGNW) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Dec 31, 2022Sep 30, 2022

Total Assets

$15.0 M(-4.2%)$15.6 M(-4.1%)$16.3 M(-1.0%)$16.5 M(-34.6%)$25.2 M(+54.3%)$16.3 M-

Current Assets

$911.0 K(-27.1%)$1.2 M(-22.3%)$1.6 M(-16.7%)$1.9 M(-81.3%)$10.3 M(+2856.9%)$350.0 K-

Non Current Assets

$14.1 M(-2.2%)$14.4 M(-2.1%)$14.7 M(+1.1%)$14.6 M(-2.0%)$14.8 M(-7.1%)$16.0 M-

Total Liabilities

$62.0 M(-27.3%)$85.4 M(+19.6%)$71.4 M(-5.1%)$75.2 M(+14.2%)$65.8 M(+345.8%)$14.8 M-

Current Liabilities

$37.1 M(-27.8%)$51.4 M(+37.1%)$37.5 M(-5.0%)$39.5 M(+1.6%)$38.8 M(+163.5%)$14.7 M-

Long Term Liabilities

$24.9 M(-26.6%)$34.0 M(+0.2%)$33.9 M(-5.1%)$35.7 M(+32.4%)$27.0 M(+103700.0%)$26.0 K-

Shareholders Equity

-$47.0 M(+32.5%)-$69.7 M(-26.6%)-$55.1 M(+6.2%)-$58.7 M(-44.4%)-$40.6 M(-2700.0%)$1.6 M-

Book Value

-$47.1 M(+32.5%)-$69.8 M(-26.6%)-$55.1 M(+6.2%)-$58.8 M(-44.3%)-$40.7 M(-2878.2%)$1.5 M-

Working Capital

-$36.2 M(+27.8%)-$50.2 M(-39.8%)-$35.9 M(+4.4%)-$37.5 M(-31.7%)-$28.5 M(-98.0%)-$14.4 M-

Cash And Cash Equivalents

$8000.0(-89.9%)$79.0 K(+132.3%)$34.0 K(+30.8%)$26.0 K(-99.7%)$8.8 M(+7409.4%)$117.0 K-

Accounts Payable

$13.5 M(+6.0%)$12.7 M(-1.1%)$12.8 M(+16.3%)$11.0 M(+39.1%)$7.9 M(+692.2%)$1.0 M-

Accounts Receivable

---$0.0(0%)$0.0(-100.0%)$29.0 K-

Short Term Debt

$19.7 M(+14.0%)$17.3 M(+49.4%)$11.6 M(+15.8%)$10.0 M(+91.0%)$5.2 M(-55.1%)$11.7 M-

Long Term Debt

$10.9 M(+1.9%)$10.7 M(+1.8%)$10.5 M(+5.7%)$9.9 M(-32.5%)$14.7 M(+100.0%)$0.0-

Total Debt

$30.7 M(+9.3%)$28.1 M(+26.6%)$22.2 M(+11.5%)$19.9 M(-0.6%)$20.0 M(+66.5%)$12.0 M-

Debt To Equity

-0.7(-62.5%)-0.4(0%)-0.4(-17.6%)-0.3(+30.6%)-0.5(-106.4%)7.7-

Current Ratio

0.0(0%)0.0(-50.0%)0.0(-20.0%)0.1(-81.5%)0.3(+1250.0%)0.0-

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$177.0 M(+3.6%)-$183.6 M(-9.6%)-$167.5 M(-3.3%)-$162.1 M(-26.1%)-$128.5 M(-62.3%)-$79.2 M-

PB Ratio

-------

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Dec 31, 2022Sep 30, 2022

EPS

-------

TTM EPS

-------

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$3000.0

TTM Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$3000.0(0%)$3000.0

Total Expenses

$6.8 M(-9.0%)$7.5 M(-2.1%)$7.6 M(-19.2%)$9.4 M(+36.6%)$6.9 M(+10.3%)$6.3 M(+4.4%)$6.0 M

Operating Expenses

$6.8 M(-9.0%)$7.5 M(-2.1%)$7.6 M(-19.2%)$9.4 M(+36.6%)$6.9 M(+10.5%)$6.2 M(+4.2%)$6.0 M

Cost Of Goods Sold

---$0.0(0%)$0.0(-100.0%)$15.0 K(+100.0%)$0.0

TTM Cost Of Goods Sold

---$0.0(-100.0%)$15.0 K(0%)$15.0 K(+100.0%)$0.0

Gross Profit

---$0.0(0%)$0.0(+100.0%)-$15.0 K(-600.0%)$3000.0

TTM Gross Profit

---$0.0(+100.0%)-$15.0 K(-25.0%)-$12.0 K(-500.0%)$3000.0

Gross Margin

------100.0%

Operating Profit

-$6.8 M(+9.0%)-$7.5 M(+2.1%)-$7.6 M(+19.2%)-$9.4 M(-36.6%)-$6.9 M(-10.3%)-$6.3 M(-4.5%)-$6.0 M

TTM Operating Profit

-$31.3 M(+0.4%)-$31.4 M(-31.1%)-$24.0 M(-46.6%)-$16.3 M(-24.1%)-$13.2 M(-7.4%)-$12.3 M(-104.5%)-$6.0 M

Operating Margin

-------199.7 K%

Net Income

$6.6 M(+141.0%)-$16.1 M(-198.9%)-$5.4 M(+84.0%)-$33.6 M(-1.3%)-$33.2 M(-377.5%)-$6.9 M(-3.8%)-$6.7 M

TTM Net Income

-$48.5 M(+45.1%)-$88.3 M(-22.3%)-$72.2 M(-8.1%)-$66.8 M(-66.4%)-$40.1 M(-194.2%)-$13.6 M(-103.8%)-$6.7 M

Net Margin

-------

EBIT

$7.1 M(+145.8%)-$15.4 M(-258.0%)-$4.3 M(+87.0%)-$33.2 M(-0.6%)-$33.0 M(-421.2%)-$6.3 M(-4.4%)-$6.1 M

TTM EBIT

-$45.8 M(+46.6%)-$85.9 M(-21.9%)-$70.4 M(-6.5%)-$66.1 M(-68.3%)-$39.3 M(-217.3%)-$12.4 M(-104.4%)-$6.1 M

EBITDA

-$9.4 M(+63.0%)-$25.5 M(-199.4%)-$8.5 M(+6.7%)-$9.1 M(+70.6%)-$31.1 M(-457.1%)-$5.6 M(+6.8%)-$6.0 M

TTM EBITDA

-$52.6 M(+29.1%)-$74.2 M(-52.4%)-$48.7 M(-21.2%)-$40.2 M(-9.7%)-$36.7 M(-217.0%)-$11.6 M(-93.2%)-$6.0 M

Selling, General & Administrative Expenses

$4.0 M(-8.3%)$4.4 M(-0.3%)$4.4 M(-17.9%)$5.3 M(+79.6%)$3.0 M(+37.8%)$2.2 M(+15.2%)$1.9 M

TTM SGA

$18.1 M(+6.1%)$17.1 M(+34.4%)$12.7 M(+52.7%)$8.3 M(+62.0%)$5.1 M(+27.3%)$4.0 M(+115.2%)$1.9 M

Depreciation And Amortization

$332.0 K(+1.8%)$326.0 K(0%)$326.0 K(+8.7%)$300.0 K(0%)$300.0 K(-59.8%)$746.0 K-

TTM D&A

$1.3 M(+2.6%)$1.3 M(+35.2%)$926.0 K(+54.3%)$600.0 K(-42.6%)$1.0 M(+40.2%)$746.0 K-

Interest Expense

$472.0 K(-27.1%)$647.0 K(-39.5%)$1.1 M(+144.1%)$438.0 K(+107.6%)$211.0 K(-65.8%)$616.0 K(-3.1%)$636.0 K

TTM Interest Expense

$2.6 M(+11.0%)$2.4 M(+37.7%)$1.7 M(+164.7%)$649.0 K(-21.5%)$827.0 K(-34.0%)$1.3 M(+96.9%)$636.0 K

Income Tax

$0.0(0%)$0.0-$7000.0(+100.0%)$0.0(-100.0%)$7000.0(+100.0%)$0.0

TTM Income Tax

$7000.0(0%)$7000.0-$7000.0(0%)$7000.0(0%)$7000.0(+100.0%)$0.0

PE Ratio

-------

PS Ratio

-------

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Dec 31, 2022Sep 30, 2022

Cash From Operations

-$3.9 M(+35.1%)-$6.0 M(-48.7%)-$4.0 M(+41.9%)-$6.9 M(-52.0%)-$4.6 M(+16.5%)-$5.5 M-

TTM CFO

-$20.9 M(+3.1%)-$21.5 M(-38.6%)-$15.5 M(-35.1%)-$11.5 M(-14.7%)-$10.0 M(-83.5%)-$5.5 M-

Cash From Investing

-$17.0 K(-13.3%)-$15.0 K(-142.9%)$35.0 K(+294.4%)-$18.0 K(-100.0%)$0.0(+100.0%)-$5000.0-

TTM CFI

-$15.0 K(-850.0%)$2000.0(-88.2%)$17.0 K(+194.4%)-$18.0 K(-260.0%)-$5000.0(0%)-$5000.0-

Cash From Financing

$3.8 M(-37.0%)$6.1 M(+51.2%)$4.0 M(+322.2%)-$1.8 M(-114.9%)$12.1 M(+120.5%)$5.5 M-

TTM CFF

$12.1 M(-40.8%)$20.4 M(+42.3%)$14.3 M(+38.8%)$10.3 M(-41.4%)$17.6 M(+220.5%)$5.5 M-

Free Cash Flow

-$3.9 M(+35.0%)-$6.0 M(-49.1%)-$4.0 M(+42.0%)-$7.0 M(-52.4%)-$4.6 M(+16.6%)-$5.5 M-

TTM FCF

-$20.9 M(+3.0%)-$21.6 M(-38.7%)-$15.6 M(-35.0%)-$11.5 M(-14.8%)-$10.0 M(-83.4%)-$5.5 M-

CAPEX

$17.0 K--$18.0 K-$5000.0-

TTM CAPEX

$35.0 K--$18.0 K-$5000.0-

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------